Official summary
What is being procured?
This call for tenders aims at speeding up the development of promising Next Generation Therapeutics for Infectious Diseases by adopting a competitive development in phases, under Pre-Commercial Procurement (PCP). The scope of the call is expected to cover the development of innovative therapeutics to treat viral infections, ARDS or sepsis resulting from infections, including pathogen-targeted therapeutics (but not small molecules or monoclonal antibodies) and host-targeted therapeutics, among which but not only direct-acting antivirals, indirect-acting antivirals and novel immune modulators. It may also cover innovative combinations therapies and products designed to be administered through alternative routes to IV.…
Notice history
Procurement timeline
Follow the main stages and updates linked to this procurement procedure.
No other related notice has been identified yet.
Data is restructured for easier reading. The official notice and procurement documents always prevail.
Source and reliability
TED · 456593-2026. Checked on Aug 23, 2026, 11:05 AM.
Data is restructured for easier reading. The official notice and procurement documents always prevail.